Leukocyte-induced acute endothelial dysfunction in middle cerebral artery in rabbits: Response to aggregating platelets

Stroke

Volumn 25, Issue 11, 1994, Pages 2246-2252

  Akopov, S E ^a   Sercombe, R ^a   Seylaz, J ^a  

^a CNRS   (France)

Author keywords

Endothelium; Leukocytes; Platelet aggregation; Vasospasm

Indexed keywords

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTERY ENDOTHELIUM; ARTICLE; BRAIN VASOSPASM; CONTROLLED STUDY; LEUKOCYTE ACTIVATION; MIDDLE CEREBRAL ARTERY; NONHUMAN; PATHOPHYSIOLOGY; PRIORITY JOURNAL; RABBIT; THROMBOCYTE AGGREGATION;

ANIMAL; CEREBRAL ARTERIES; DOSE-RESPONSE RELATIONSHIP, DRUG; ENDOTHELIUM, VASCULAR; ISCHEMIC ATTACK, TRANSIENT; LEUKOCYTES; N-FORMYLMETHIONINE LEUCYL-PHENYLALANINE; OSMOLAR CONCENTRATION; PLATELET AGGREGATION; RABBITS; SUPPORT, NON-U.S. GOV'T; TETRADECANOYLPHORBOL ACETATE; TIME FACTORS; VASODILATOR AGENTS;

EID: 0028063334     PISSN: 00392499     EISSN: 15244628     Source Type: Journal    
DOI: 10.1161/01.STR.25.11.2246     Document Type: Article

References (41)

1. Mehta JL, Nicolini FA, Donnelly WH, Nichols WW. Plateletleukocyte-endothelial interactions in coronary artery disease. Am J Cardiol. 1992;69:8B-13B.
2. Kochanek PM, Hallenbeck JM. Potymorphonuclear leukocytes and monocytes/macrophages in the pathogenesis of cerebral ischemia and stroke. Stroke. 1992;23:1367-1379.
3. Gillespie MN, Booth DC, Friedman BJ, Cunningham MR, Jay M, DeMaria AN. fMLP provokes coronary vasoconstriction and myocardial ischemia in rabbits. Am J Physiol. 1988;254:H481-H486.
4. Lopez JAG, Armstrong ML, Harrison DG, Piegors DJ, Heistad DD. Vascular responses to leukocyte products in atherosclerotic primates. Circ Res. 1989;65:1078-1086.
5. Myers ML, Webb C, Moffat M, Mclver D, Maestro R. Activated neutrophils depress myocardial function in the perfused rabbit heart Can J Cardiol. 1991;7:323-330.
6. Faraci FM, Lopez AG, Breese K, Armstrong ML, Heistad DD. Effect of atherosclerosis on cerebral vascular responses to activation of leukocytes and platelets in monkeys. Stroke. 1991;22:790-796.
7. Faraci FM, Heistad DD. Regulation of large cerebral arteries and cerebral microvascular pressure. Oirc Res. 1990;66:8-17.
8. Ohlstein EH, Nichols AJ. Rabbit porymorphonudear neutrophils elicit endothelium-dependent contraction in vascular smooth muscle. Cur Fcs, 1989;65:917-924.
9. Nishida M, Kuzuya T, Hoshida S, Kim Y, Kitabatake A, Kamada T, Tada M. Porymorphonuclear leukocytes induced vasoconstriction in isolated canine coronary arteries. Oirc Res. 1990;66:253-258.
10. Mügge A, Heistad DD, Padgett RC, Waack BJ, Densen P, Lopez JAG. Mechanisms of contraction induced by human leukocytes in normal and atherosclerotic arteries. Oirc Res. 1991;69:871-880.
11. Akopov SE, Grygorian MR, Gabrielian ES, Balayan BH. Investigation of the dependence of human middle artery contractile activity on the presence of an atherosclerotic patch. Heart Vessels. 1992;7:196-199.
12. Mullane KM, Salmon JA, Kraemer R. Leukocyte-de rived metabolites of arachidonic acid in ischemia-induced myocardial injury. FedProc. 1987;46:2422-2433.
13. Akopov SE, Grigorian MR, Gabrielian ES. The endothelium-dependent relaxation of human middle cerebral artery: effect of activated neutrophils. Expcrientia. 1992;48:34-36.
14. Liu JJ, Chen JR, Wiley J, Johnston CC, Buxton BF. Inhibition by a stable factor derived from neutrophils of endothelium-dependent relaxation in rat aorta. Am J Physiol. 1993;265:H1454-H1459.
15. De Kimpe SJ, Van Heuven-Nolsen D, Nijkamp FP. Acetylcholine-induced relaxation in bovine isolated mesenteric arteries is supressed by porymorphonuclear leukocytes. Br J PharmacoL 1993;109:8-13.
16. Passero S, Battistini N, Fieshi C. Platelet embolism in rabbit brain. Stroke. 1981;12:781-786.
17. O’Flaherty J, Cousart S, Lineberger A, Bond E, Bass D, Dechatelet L, Leake E, McCall C. Phorbol myristate acetate: in vivo effects upon neutrophils, platelets, and lung. Am J Pathol. 1980;101:79-92.
18. Mizer LA, Weisbrode SE, Dorinsky PM. Neutrophil accumulation and structural changes in nonpulmonary organs after acute lung injury induced by phorbol myristate acetate. Am Rev Respir Dis. 1989;139:1017-1026.
19. Akopov S, Ghazarian A, Gabrielian E. Effects of nimodipine and nicergoline on cerebrovascular injuries induced by activation of platelets and leukocytes in vivo. Arch Int Pharmacodyn Ther. 1992;318:66-75.
20. Lafuze JE, Baker MD, Oakes AL, Baehner RL. Comparison of in vivo effects of intravenous infusion of N-formyl-methionylleucylphenylalanine and phorbol myristate acetate in rabbits. Inflammation. 1987;11:481-488.
21. Fieschi C, Battistini N, Volante F, Zanette E, Passero S. Animal model of TIA: an experimental study with intracarotid ADP infusion in rabbits. Stroke. 1975;6:617-621.
22. Sercombe R, Verrecchia C, Oudart N, Dimitriadou V, Seylaz J. Pial artery responses to norepinephrine potentiated by endothelium removal. J Cereb Blood Flow Metab. 1985;5:312-317.
23. Debdi M, Seylaz J, Sercombe R. Early changes in rabbit cerebral artery reactivity after subarachnoid hemorrhage. Stroke. 1992;23:1154-1162.
24. Pearson PJ, Schaff HV, Vanhoutte PM. Acute impairment of endothelium-dependent relaxations to aggregating platelets following reperfusion injury in canine coronary arteries. Circ Res. 1990;67:385-393.
25. Shimokawa H, Aarhus LL, Vanhoutte PM. Porcine coronary arteries with regenerated endothelium have a reduced endothelium-dependent responsiveness to aggregating platelets and serotonin. Circ Res. 1987;61:256-270.
26. Helps SC, Gorman DF. Air embolism in rabbits pretreated with mechlorethamine. Stroke. 1991;22:351-354.
27. Rowe GT, Eaton L, Hess ML. Neutrophil-derived, oxygen free radical-mediated cardiovascular dysfunction. J Mol Cell Cardiol. 1984;16:1075-1079.
28. Gillespie MN, Kojima S, Kunitomo M, Jay M. Coronary and myocardial effects of activated neutrophils in perfused rabbit hearts. J Pharmacol Exp Ther. 1986;239:836-840.
29. Karmazyn M, Watson JE, Moffat MP. Mechanisms for cardiac depression induced by phorbol myristate acetate in working rat hearts. Br J Pharmacol. 1990;100:826-830.
30. Uhl MW, Kochanek PM, Schiding JK, Nemoto EM. Effect of phorbol myristate acetate on cerebral blood flow in normal and neutrophil-depleted rats. Stroke. 1993;24:1977-1982.
31. Sessa WC, Mullane KM. Release of neutrophi l-derived vasoconstrictor agent which augments platelet-induced contraction of blood vessels in vitro. Br J Pharmacol. 1990;99:553-559.
32. Petitclerc E, Marceau F. Relaxant effect of chemotactic peptides on rabbit vascular strips: evidence for nitric oxide release from a nonendothelial source. Blood Vessels. 1991;28:452-463.
33. Flavahan NA, Shimokawa H, Vanhoutte PM. Inhibition of endo-thelium-dependent relaxation by phorbol myristate acetate in canine coronary arteries: role of a pertussis toxin selective G-protein. J Pharmacol Exp Ther. 1991;256:50-55.
34. Akopov SE. Blood cells interaction and antiplatelet therapy: a review. Drugs of Today. 1992;28:405-420.
35. Gudewicz PW, Weaver MB, Del Vecchio PJ, Saba TM. Phorbol myristate acetate-treated endothelium stimulates polymorphonuclear leukocyte adhesion and superoxide secretion. J Lab Clin Med. 1989;113:708-716.
36. Lucchesi BR. Complement activation, neutrophils, and oxygen radicals in reperfusion injury. Stroke. 1993;24(suppl I):I-41-I-49.
37. Sobey CG, Woodman OL. Myocardial ischemia: what happens to the coronary arteries? Trends Pharmacol Sci. 1993;14:448-453.
38. Feldman RL. Coronary thrombosis, coronary spasm and coronary atherosclerosis and speculation on the link between unstable angina and acute myocardial infarction. Am J Cardiol. 1986;59:1187-1190.
39. Shepherd JT, Vanhoutte PM. Mechanism response for coronary vasospasm. J Am Coll Cardiol. 1986;8:50-54.
40. Shimokawa H, Kim P, Vanhoutte PM. Endothelium-dependent relaxation to aggregating platelets in isolated basilar arteries of control and hypercholesterolemic pigs. Circ Res. 1988;63:604-612.
41. Frerichs KU, Feuerstein GZ. Platelet-activating factor: key mediator in neuroinjury? Cerebrovasc Brain Metab Rev. 1990;2:148-160.